NHS backs delayed‑release treatment for cystinosis
Decision expands options for eligible patients NHS England has recommended delayed‑release mercaptamine bitartrate for routine commissioning for eligible patients aged one year and above with nephropathic cystinosis. The decision provides…
NHS to lose out on new drugs, pharma firm warns
NHS patients will lose access to new cutting-edge treatments because of skyrocketing costs, the pharmaceutical giant Novartis has claimed amid a row over drug pricing deals. The warning comes after…
